Michael Richman is a director of Pieris Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NextCure, Inc.
2 Apr 24
4
NextCure, Inc.
1 Feb 24
4
PIERIS PHARMACEUTICALS, INC.
23 Jun 23
4
NextCure, Inc.
1 Mar 23
4
PIERIS PHARMACEUTICALS, INC.
24 Jun 22
4
NextCure, Inc.
2 Feb 22
4
PIERIS PHARMACEUTICALS, INC.
29 Jun 21
4
NextCure, Inc.
16 Mar 21
4
PIERIS PHARMACEUTICALS, INC.
25 Jun 20
4
NextCure, Inc.
3 Mar 20
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 Mar 24 | NXTC NextCure | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.23 | 244,400 | 545.01 k | 244,400 |
| 31 Jan 24 | NXTC NextCure | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.22 | 305,500 | 372.71 k | 305,500 |
| 21 Jun 23 | PIRS Pieris Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 0.26 | 40,000 | 10.40 k | 40,000 |